High-flow Nasal Cannula Market Size & Share, by Type (Active Humidifier, Single Heated Tube, Air Blender, Nasal Cannula); Application (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Acute Heart failure); End-user (Hospitals & Clinics, Ambulatory Care Centers, Long-Term Care Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4575
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2033

High Flow Nasal Cannula Market size is anticipated to reach USD 17 Billion by the end of 2033, growing at a CAGR of 12% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of high flow nasal cannula was USD 9 Billion. The growth of the market is primarily attributed to the radically increasing cases of asthma along with chronic obstructive pulmonary diseases across the globe. As per the World Health Organization, globally, asthma is expected to have killed 455 000 people in 2019 and impacted 262 million people in the same year. Increasing air pollution is caused by the presence of particulate matter and ozone, and an increasing number of indoor air pollutants, which include tobacco smoke, dust mites, cockroaches, mold & pesticides. The pollution caused by fossil fuel combustion, the growing number of industries, transportation, and the rising use of chemicals across the world is estimated to propel the growth of the market.

The nasal cannula is used in cases where people are not able to breathe or get sufficient oxygen for the proper functioning of the body. This is a common phenomenon among patients who are suffering from asthma, COPD, or any other respiratory illness. In addition to this, the high-flow nasal cannula market is estimated to grow on the basis of the rising prevalence of asthma and respiratory tract illnesses among children across the world. Also, asthma is the most common chronic condition affecting children as per the reports. As per the estimations, about 5.1 million asthmatic children are under the age of 18. Moreover, about, 11 Americans die from asthma every day, and asthma-related deaths reached to 4,145 in the year 2020. Besides this, the launch of novel advanced products by the key manufacturers is another major factor that is fueling the growth of the market over the projected period.

High-flow Nasal Cannula Market
Get more information on this report: Request Free Sample PDF

High-flow Nasal Cannula Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Geriatric Population across the Globe with Reduced Immunity – In people 65 years of age or older, asthma is common. Asthma affects about 7.8% of older individuals in the US. Asthma and other respiratory illnesses are frequent and more common in elderly people. With aging, the immunity to fight back illness slows down and, with that, the geriatric population becomes more prone to chronic illness. Hence, the rising geriatric population and the increasing prevalence of asthma among the elderly are estimated to drive high-flow nasal cannula market growth.
  • Growing Investment in Research and Development Owing to Increasing Funds – According to data compiled by the World Bank, the global research and development expenditures made up 2.23% of GDP in 2018.
  • Increasing Spending on Healthcare with Rising Awareness of Health Among People – For instance, in the last 20 years, global health spending has increased overall and reached USD 8.5 trillion in 2019 with 9.8% of GDP, up from 8.5 percent in 2000.
  • Rising Prevalence of Asthma with Rising Respiratory Diseases – The increasing demand for the chronic respiratory diseases treatment is expected to boost the market’s growth in the upcoming years. Over 20 million Americans above the age of 18 suffer from asthma, and adult females are more likely than adult males to be affected. Compared to 6.1 percent of adult males, it affects roughly 9.8 percent of adult females.
  • Growing Adoption of Ambulatory Surgeries Around the World – It was observed that over the past 25 years, the number of ambulatory surgeries performed at community hospitals in the United States has steadily increased, rising from 13.4 million in 1995 to 19.2 million in 2018.


  • Side Effects of Using High Flow Nasal Cannula – While using high flow nasal cannulas, unwarmed and dry gas is estimated to be harmful to people with respiratory failure. Breathing dry air produces excessive water loss by the nasal mucosa, which may limit the nasal mucociliary clearance rate through alterations in the rheological characteristics or adhesiveness of nasal mucus and/or ciliary pulse shortening. This factor is anticipated to hinder the growth of the high-flow nasal cannula market during the forecast period.
  • Suitability Issues for Long-Term Usage
  • High Cost of the Product in the Market

High-flow Nasal Cannula Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~ USD 9 Billion

Forecast Year Market Size (2033)

~ USD 17 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

High-flow Nasal Cannula Segmentation

Application (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Acute Heart failure)

The global high-flow nasal cannula market is segmented and analyzed for demand and supply by application into acute respiratory failure, chronic obstructive pulmonary disease (COPD), acute heart failure, and others. Among these segments, the COPD segment is estimated to garner the largest market share as per the market analysis. COPD is a common pulmonary disease that affects the lungs of the patient. Furthermore, the increasing number of COPD cases is owing to the growing occupational inhalation of chemicals or dust. In addition, long-term exposure to tobacco smoke, indoor air pollution from allergens including animal fur, plant pollen, cooking smoke from cow dung or wood, the presence of respiratory infections, and any genetic deficiency are estimated to cause COPD. Across the world, over 3.23 million people died from COPD in 2019, as per the World Health Organization. The treatment with the high flow oxygen via nasal cannula helps to reduce respiratory rate and supports COPD patients with acute hypercapnic respiratory illness. It improves gas exchange in the blood to purify deoxygenated blood. This increase in demand for high flow nasal cannula application in COPD patients is anticipated to surge the segment’s growth in the market.

End-user (Hospitals & Clinics, Ambulatory Care Centers, Long-Term Care Centers)

The global high-flow nasal cannula market is also segmented and analyzed for demand and supply by end-user into hospitals and clinics, ambulatory care centers, long-term care centers, and others. Out of these, the hospitals & clinics segment is estimated to gain the largest market share by the end of 2033 on the back of the requirement for high flow nasal cannulas in hospitals and clinics, which is based on usage for a predetermined number of patients. Moreover, the number of hospitals and surgeries is growing, thus increasing the usage of the nasal cannula in the hospital is further predicted to boost the segment’s growth in the market. Further, approximately 40 to 50 million major surgeries are performed in the USA every year, and about 20 million in Europe, out of 310 million surgeries across the world.  

Our in-depth analysis of the global market includes the following segments:

                By Type

  • Active Humidifier
  • Single Heated Tube
  • Air Blender
  • Nasal Cannula

                By Application

  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease
  • Acute Heart failure
  • Others

                 By End-User

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Long-Term Care Centers
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

High-flow Nasal Cannula Industry - Regional Synopsis

APAC Market Statistics

The Asia Pacific high-flow nasal cannula market is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the growing geriatric and pediatric population, along with the increasing prevalence of asthma in the region. By 2050, one in four individuals in the region of Asia Pacific is estimated to get older than 60, and the incidence of asthma in the elderly population is about 1.3 to 15.3% compared to 5 percent of adults in the region, as per the reports. Moreover, with the rising cases of chronic respiratory diseases, there is also a surge in the number of surgeries conducted in the region every year. Along with this, the growing healthcare infrastructure, and improving healthcare facilities in the region are estimated to drive market growth in the region during the forecast period. The increasing urbanization from growing industries releases harmful gases and chemicals into the environment. In addition, the increasing automobile industry is also estimated to rise air pollution owing to elevating vehicles on the road.

Research Nester
High-flow Nasal Cannula Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the High-flow Nasal Cannula Landscape

    • Armstrong Medical Ltd
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Eakin Healthcare Group
    • ResMed Corp.
    • Teleflex Incorporated
    • Vapotherm, Inc.
    • Becton, Dickinson, and Company
    • Smiths Group plc
    • CU Medical Systems, Inc
    • Flexicare Medical Limited


In The News

  • ResMed Corp. As per an abstract submitted at the European Respiratory Society Congress organized by ResMed, more than 480 million people are suffering from COPD worldwide.

  • Eakin Healthcare Group – Eakin Healthcare Group acquired Coleraine-based Armstrong Medical, which specialized in respiratory care products, and its headquarters is located at Northern Ireland.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4575
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising geriatric population, growing investment in research and development are the major factors driving the market growth.

The market is anticipated to attain a CAGR of ~12% over the forecast period, i.e., 2023-2033.

The side effects and high cost of the product are estimated to be the restraining factor for the market growth.

The market in Asia Pacific region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Armstrong Medical Ltd, Eakin Healthcare Group, ResMed Corp., Teleflex Incorporated, Vapotherm, Inc., Becton, Dickinson and Company, Smiths Group plc, CU Medical Systems, Inc, Flexicare Medical Limited, TEIJIN LIMITED.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, application, end user, and by region.

The hospitals and clinic segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
High-flow Nasal Cannula Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying